Mr. Wu is the Non-Executive Chairman and is the Chairman of the Remuneration Committee of the Company and founder of the Group, which has over 20 years’ history of business and investment focused in the PRC. He was born and educated in Beijing and is a graduate of Beijing Industrial University. He also has a degree in Business Administration. Following a period as a senior executive in government scientific institutes, he held posts as managing director of two newly established state owned financial institutions. Since 1988 Mr. Wu has, through companies, invested in and developed the Landmark Hotel (now called Crowne Plaza Hotel & Suites Landmark Shenzhen) in Shenzhen and established the Cathay International Water Limited group of companies, which made substantial investments in public utility and infrastructure in the PRC. Strategic shareholders were JP Morgan, Singapore Technologies, UBS, Banco Santander and Nomura JAFCO, and this business was once the largest foreign investor in water and waste water treatment projects in the PRC with net assets of over USD1 billion. Since 30 March 2017, Mr. Wu has been the Chairman of the Board and Chairman of the Executive Committee of the Company’s subsidiary, Lansen Pharmaceutical Holdings Limited, which is listed on the Hong Kong Stock Exchange.